Infection Surveillance Services Market by Offering (Software and Services), Infection Type (Hospital-acquired Pneumonia, Bloodstream Infections, Surgical Site Infections, Gastrointestinal Infections, Urinary Tract Infections (UTIs), and Others), and End User (Hospitals & Clinics, Ambulatory Surgical Centers & Academic Institutes, and Long-term Care Facilities): Global Opportunity Analysis and Industry Forecast, 2021––2030
- ALL4676755
- 246 Pages
- August 2021
- Medical Devices
The infection surveillance service provides information and instruction for national surveillance of healthcare-associated infections such as surgical site infection, pneumonia, and urinary tract infection. The healthcare-associated infection, also known as hospital-acquired infections, are nosocomial-acquired infections in which individuals are infected while receiving healthcare treatment for another medical condition. The infection surveillance services analyze the collected data to improve understanding of surgical site infection epidemiology.
The growth of the global infection surveillance services market is majorly driven by an alarming increase in the prevalence of healthcare-associated infection, such as urinary tract infection, pneumonia, and surgical site infection; rise in government initiatives for the prevention and control of healthcare-associated infections; surge in number of surgical procedures; rise in adoption of infection surveillance software among healthcare workers; and resistance of microbes and bacteria toward antibiotics. For instance, according to the Office of Disease prevention and health promotion (ODPHD), approximately 1 in 25 inpatients are diagnosed with healthcare-associated infections during hospital care. Moreover, the Ministry of Health & family welfare, Government of India effectively runs a program under the National Health Mission, named as Integrated Disease Surveillance Programme (IDSP). It aims to maintain decentralized laboratory-based on information technology (IT), which enables the disease surveillance system to detect infectious diseases through trained Rapid Response Team (RRTs). Furthermore, in 2019, GOJO Industries, Inc., a global leader in producing and marketing hygiene solutions, expanded the PURELL SMARTLINK portfolio along with an individual monitoring solution to be used in hospitals for combating healthcare-associated infections. Thus, advancements in technology in the healthcare sector and rise in prevalence of healthcare-associated infections are expected to propel the growth of the market.
Increase in the number of surgical procedures and surge in demand for automated healthcare-associated infection surveillance are the major factors that drive the global infection surveillance services market. Moreover, increase in prevalence of surgical site infection significantly contributes toward the market growth, owing to the fact that increase in number of surgical procedures leads to increased stays in hospitals, and as a result, the number of patients suffering from healthcare-associated infections increases. Rise in demand for use of advanced analytical process software for infection surveillance solution acts a key driving force of the global market. Furthermore, governments are taking multiple initiatives to support the development of information technology in the healthcare sector, which is expected to boost the market growth. In 2020, Amazon launched Amazon HealthLake, which is a Health Insurance Portability and Accountability Act (HIPAA)—eligible service for healthcare and life science organizations. It allows healthcare organizations to store, index, tag, query, and use machine earning to analyze data at petabyte scale in the cloud. Furthermore, increase in capacity of information technology system to perform analysis & infection surveillance solution for use in the healthcare sector propels the growth of the market. In addition, rise in infection caused due to lack of sanitation & medical devices and rise in antibiotic resistance by bacteria are anticipated to provide lucrative opportunities for the market expansion.
On the contrary, high cost of software associated with infection surveillance services is anticipated to hinder the market growth during the forecast period. Conversely, rise in adoption of software analytical tools such as electronic medical records contributes toward the market growth. This encourages many key players to enter into emerging markets, thus offering a lucrative growth opportunities for the infection surveillance services market.
The global infection surveillance services market is segmented into of offering, infection type, end user, and region. By offering, the market is categorized into software and services. The software segment is further classified into on-premise and web-based. The services segment is subdivided into product support & maintenance services, training & consulting services, and implementation services. Depending on infection type, the market is segregated into hospital-acquired pneumonia, bloodstream infections, surgical site infections, gastrointestinal infections, urinary tract infections (UTI), and others.
On the basis of end user, the market is fragmented into hospitals & clinics, ambulatory surgical centers & academic institutes, and long-term care facilities. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Some of the major companies that operate in the global infection surveillance services market are Alpha Source Inc., Baxter International Inc., Becton, Dickinson and Company, BioVigil, Gojo Industries Inc., International Business Machines Corporation, Premier Inc., RLDatix, S. C. Johnson & Son, Inc., and Wolters Kluwer.
KEY BENEFITS FOR STAKEHOLDERS
The report provides an in-depth analysis of the global infection surveillance services market size along with the current trends and future estimations to elucidate the imminent investment pockets.
It offers market analysis from 2021 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
A comprehensive analysis on region assists to understand the regional market and facilitate the strategic business planning and determine prevailing opportunities.
The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global infection surveillance services market.
KEY MARKET SEGMENTS
By Offering
• Software
o On-premise
o Web-based
• Services
o Product Support & Maintenance Services
o Training & Consulting Services
o Implementation Services
By Infection Type
• Hospital-acquired Pneumonia
• Bloodstream Infections
• Surgical Site Infections
• Gastrointestinal Infections
• Urinary Tract Infections (UTIs)
• Others
By End User
• Hospitals & Clinics
• Ambulatory Surgical Centers & Academic Institutes
• Long-term Care Facilities
•
By Region
o North America
U.S.
Canada
Mexico
o Europe
Germany
France
UK
Italy
Spain
Rest of Europe
o Asia-Pacific
Japan
China
Australia
India
Rest of Asia-Pacific
o LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
KEY MARKET PLAYERS
• Alpha Source Inc.
• Baxter International Inc.
• Becton, Dickinson and Company
• BioVigil
• Gojo Industries Inc.
• International Business Machines Corporation
• Premier Inc.
• RLDatix
• S. C. Johnson & Son, Inc.
• Wolters Kluwer
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET LANDSCAPE
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.Porter’s five forces analysis
3.4.Top player positioning, 2020
3.5.Market dynamics
3.5.1.Drivers
3.5.1.1.Increase in prevalence of healthcare associated infection
3.5.1.2.Technological advancement in healthcare sector
3.5.1.3.Initiative taken by government for prevention of healthcare associated infection
3.5.2.Restraint
3.5.2.1.High cost of software associated with infection surveillance solution
3.5.3.Opportunity
3.5.3.1.Growing opportunities in emerging market and development in healthcare industry
3.5.4.Impact analysis
3.6.Impact analysis of COVID-19 on the infection surveillance services market
CHAPTER 4:INFECTION SURVEILLANCE SERVICES MARKET, BY OFFERING
4.1.Overview
4.1.1.Market size and forecast
4.2.Software
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Software, by Type
4.2.2.1.Market size and forecast
4.2.2.2.On-premise
4.2.2.2.1.Market size and forecast
4.2.2.3.Web-based
4.2.2.3.1.Market size and forecast
4.2.3.Market size and forecast, by region
4.2.4.Market analysis, by country
4.3.Services
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Services, by type
4.3.2.1.Market size and forecast
4.3.2.2.Product Support & Maintenance Services
4.3.2.2.1.Market size and forecast
4.3.2.3.Training & Consulting Services
4.3.2.3.1.Market size and forecast
4.3.2.4.Implementation Services
4.3.2.4.1.Market size and forecast
4.3.3.Market size and forecast, by region
4.3.4.Market analysis, by country
CHAPTER 5:INFECTION SURVEILLANCE SERVICES MARKET, BY INFECTION TYPE
5.1.Overview
5.1.1.Market size and forecast
5.2.Hospital-acquired pneumonia
5.2.1.Key market trends, growth factors, and opportunities
5.2.2.Market size and forecast, by region
5.2.3.Market analysis, by country
5.3.Bloodstream infections
5.3.1.Key market trends, growth factors, and opportunities
5.3.2.Market size and forecast, by region
5.3.3.Market analysis, by country
5.4.Surgical site infections
5.4.1.Key market trends, growth factors, and opportunities
5.4.2.Market size and forecast, by region
5.4.3.Market analysis, by country
5.5.Gastrointestinal infections
5.5.1.Key market trends, growth factors, and opportunities
5.5.2.Market size and forecast, by region
5.5.3.Market analysis, by country
5.6.Urinary Tract Infections (UTI)
5.6.1.Key market trends, growth factors, and opportunities
5.6.2.Market size and forecast, by region
5.6.3.Market analysis, by country
5.7.Others
5.7.1.Key market trends, growth factors, and opportunities
5.7.2.Market size and forecast, by region
5.7.3.Market analysis, by country
CHAPTER 6:INFECTION SURVEILLANCE SERVICES MARKET, BY END USER
6.1.Overview
6.1.1.Market size and forecast
6.2.Hospitals & Clinics
6.2.1.Key market trends, growth factors, and opportunities
6.2.2.Market size and forecast, by region
6.2.3.Market analysis, by country
6.3.Ambulatory Surgical Centers & Academic Institutes
6.3.1.Key market trends, growth factors, and opportunities
6.3.2.Market size and forecast, by region
6.3.3.Market analysis, by country
6.4.Long term Care facilities
6.4.1.Key market trends, growth factors, and opportunities
6.4.2.Market size and forecast, by region
6.4.3.Market analysis, by country
CHAPTER 7:INFECTION SURVEILLANCE SERVICES MARKET, BY REGION
7.1.Overview
7.1.1.Market size and forecast
7.2.North America
7.2.1.Key market trends, growth factors, and opportunities
7.2.2.North America infection surveillance services market, by offering
7.2.3.North America infection surveillance services market, by infection type
7.2.4.North America infection surveillance services market, by end user
7.2.5.Market size and forecast, by country
7.2.5.1.U.S.
7.2.5.1.1.U.S. infection surveillance services market, by offering
7.2.5.1.2.U.S. infection surveillance services market, by infection type
7.2.5.1.3.U.S. infection surveillance services market, by end user
7.2.5.2.Canada
7.2.5.2.1.Canada infection surveillance services market, by offering
7.2.5.2.2.Canada infection surveillance services market, by infection type
7.2.5.2.3.Canada infection surveillance services market, by end user
7.2.5.3.Mexico
7.2.5.3.1.Mexico infection surveillance services market, by offering
7.2.5.3.2.Mexico infection surveillance services market, by infection type
7.2.5.3.3.Mexico infection surveillance services market, by end user
7.3.Europe
7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Europe infection surveillance services market, by offering
7.3.3.Europe infection surveillance services market, by infection type
7.3.4.Europe infection surveillance services market, by end user
7.3.5.Market size and forecast, by country
7.3.5.1.Germany
7.3.5.1.1.Germany infection surveillance services market, by offering
7.3.5.1.2.Germany infection surveillance services market, by infection type
7.3.5.1.3.Germany infection surveillance services market, by end user
7.3.5.2.France
7.3.5.2.1.France infection surveillance services market, by offering
7.3.5.2.2.France infection surveillance services market, by infection type
7.3.5.2.3.France infection surveillance services market, by end user
7.3.5.3.UK
7.3.5.3.1.UK infection surveillance services market, by offering
7.3.5.3.2.UK infection surveillance services market, by infection type
7.3.5.3.3.UK infection surveillance services market, by end user
7.3.5.4.Italy
7.3.5.4.1.Italy infection surveillance services market, by offering
7.3.5.4.2.Italy infection surveillance services market, by infection type
7.3.5.4.3.Italy infection surveillance services market, by end user
7.3.5.5.Spain
7.3.5.5.1.Spain infection surveillance services market, by offering
7.3.5.5.2.Spain infection surveillance services market, by infection type
7.3.5.5.3.Spain infection surveillance services market, by end user
7.3.5.6.Rest of Europe
7.3.5.6.1.Rest of Europe infection surveillance services market, by offering
7.3.5.6.2.Rest of Europe infection surveillance services market, by infection type
7.3.5.6.3.Rest of Europe infection surveillance services market, by end user
7.4.Asia-Pacific
7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Asia-Pacific infection surveillance services market, by offering
7.4.3.Asia-Pacific infection surveillance services market, by infection type
7.4.4.Asia-Pacific infection surveillance services market, by end user
7.4.5.Market size and forecast, by country
7.4.5.1.Japan
7.4.5.1.1.Japan infection surveillance services market, by offering
7.4.5.1.2.Japan infection surveillance services market, by infection type
7.4.5.1.3.Japan infection surveillance services market, by end user
7.4.5.2.China
7.4.5.2.1.China infection surveillance services market, by offering
7.4.5.2.2.China infection surveillance services market, by infection type
7.4.5.2.3.China infection surveillance services market, by end user
7.4.5.3.Australia
7.4.5.3.1.Australia infection surveillance services market, by offering
7.4.5.3.2.Australia infection surveillance services market, by infection type
7.4.5.3.3.Australia infection surveillance services market, by end user
7.4.5.4.India
7.4.5.4.1.India infection surveillance services market, by offering
7.4.5.4.2.India infection surveillance services market, by infection type
7.4.5.4.3.India infection surveillance services market, by end user
7.4.5.5.Rest of Asia-Pacific
7.4.5.5.1.Rest of Asia-Pacific infection surveillance services market, by offering
7.4.5.5.2.Rest of Asia-Pacific infection surveillance services market, by infection type
7.4.5.5.3.Rest of Asia-Pacific infection surveillance services market, by end user
7.5.LAMEA
7.5.1.Key market trends, growth factors, and opportunities
7.5.2.LAMEA infection surveillance services market, by offering
7.5.3.LAMEA infection surveillance services market, by infection type
7.5.4.LAMEA infection surveillance services market, by end user
7.5.5.Market size and forecast, by country
7.5.5.1.Brazil
7.5.5.1.1.Brazil infection surveillance services market, by offering
7.5.5.1.2.Brazil infection surveillance services market, by infection type
7.5.5.1.3.Brazil infection surveillance services market, by end user
7.5.5.2.Saudi Arabia
7.5.5.2.1.Saudi Arabia infection surveillance services market, by offering
7.5.5.2.2.Saudi Arabia infection surveillance services market, by infection type
7.5.5.2.3.Saudi Arabia infection surveillance services market, by end user
7.5.5.3.South Africa
7.5.5.3.1.South Africa infection surveillance services market, by offering
7.5.5.3.2.South Africa infection surveillance services market, by infection type
7.5.5.3.3.South Africa infection surveillance services market, by end user
7.5.5.4.Rest of LAMEA
7.5.5.4.1.Rest of LAMEA infection surveillance services market, by offering
7.5.5.4.2.Rest of LAMEA infection surveillance services market, by infection type
7.5.5.4.3.Rest of LAMEA infection surveillance services market, by end user
CHAPTER 8:COMPANY PROFILES
8.1.ALPHA SOURCE INC.
8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.2.BAXTER INTERNATIONAL INC
8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio
8.2.5.Business performance
8.2.6.Key strategic moves and developments
8.3.BECTON, DICKINSON, AND COMPANY
8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.3.5.Business performance
8.4.BIOVIGIL
8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.4.5.Key strategic moves and developments
8.5.GOJO INDUSTRIES INC.
8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio
8.6.INTERNATIONAL BUSINESS MACHINES CORPORATION
8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio
8.6.5.Business performance
8.7.PREMIER INC.
8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.7.5.Business performance
8.7.6.Key strategic moves and developments
8.8.RL DATIX
8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.8.5.Key strategic moves and developments
8.9.S. C. JOHNSON & SON, INC.
8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.9.5.Key strategic moves and developments
8.10.WOLTERS KLUWER
8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio
8.10.5.Business performance
8.10.6.Key strategic moves and developments
TABLE 01.GLOBAL INFECTION SURVEILLANCE SERVICES MARKET, BY OFFERING, 2020-2030 ($MILLION)
TABLE 02.SOFTWARE MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 03.INFECTION SURVEILLANCE SERVICES MARKET FOR SOFTWARE, BY REGION, 2020-2030 ($MILLION)
TABLE 04.SERVICES MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 05.INFECTION SURVEILLANCE SERVICES MARKET FOR SERVICES, BY REGION, 2020-2030 ($MILLION)
TABLE 06.GLOBAL INFECTION SURVEILLANCE SERVICES MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 07.INFECTION SURVEILLANCE SERVICES MARKET FOR HOSPITAL-ACQUIRED PNEUMONIA, BY REGION, 2020-2030 ($MILLION)
TABLE 08.INFECTION SURVEILLANCE SERVICES MARKET FOR BLOODSTREAM INFECTION, BY REGION, 2020-2030 ($MILLION)
TABLE 09.INFECTION SURVEILLANCE SERVICES MARKET FOR SURGICAL SITE INFECTION, BY REGION, 2020-2030 ($MILLION)
TABLE 10.INFECTION SURVEILLANCE SERVICES MARKET FOR GASTROINTESTINAL INFECTIONS, BY REGION, 2020-2030 ($MILLION)
TABLE 11.INFECTION SURVEILLANCE SERVICES MARKET FOR URINARY TRACT INFECTIONS (UTI), BY REGION, 2020-2030 ($MILLION)
TABLE 12.INFECTION SURVEILLANCE SERVICES MARKET FOR OTHERS, BY REGION, 2020-2030 ($MILLION)
TABLE 13.GLOBAL INFECTION SURVEILLANCE SERVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 14.INFECTION SURVEILLANCE SERVICES MARKET FOR HOSPITALS & CLINICS, BY REGION, 2020-2030 ($MILLION)
TABLE 15.INFECTION SURVEILLANCE SERVICES MARKET FOR AMBULATORY SURGICAL CENTERS & ACADEMIC INSTITUTES, BY REGION, 2020-2030 ($MILLION)
TABLE 16.INFECTION SURVEILLANCE SERVICES MARKET FOR LONG TERM CARE FACILITIES, BY REGION, 2020-2030 ($MILLION)
TABLE 17.INFECTION SURVEILLANCE SERVICES MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 18.NORTH AMERICA INFECTION SURVEILLANCE SERVICES MARKET, BY OFFERING, 2020-2030 ($MILLION)
TABLE 19.NORTH AMERICA INFECTION SURVEILLANCE SERVICES MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 20.NORTH AMERICA INFECTION SURVEILLANCE SERVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 21.NORTH AMERICA INFECTION SURVEILLANCE SERVICES MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 22.U.S. INFECTION SURVEILLANCE SERVICES MARKET, BY OFFERING, 2020-2030 ($MILLION)
TABLE 23.U.S. INFECTION SURVEILLANCE SERVICES MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 24.U.S. INFECTION SURVEILLANCE SERVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 25.CANADA INFECTION SURVEILLANCE SERVICES MARKET, BY OFFERING, 2020-2030 ($MILLION)
TABLE 26.CANADA INFECTION SURVEILLANCE SERVICES MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 27.CANADA INFECTION SURVEILLANCE SERVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 28.MEXICO INFECTION SURVEILLANCE SERVICES MARKET, BY OFFERING, 2020-2030 ($MILLION)
TABLE 29.MEXICO INFECTION SURVEILLANCE SERVICES MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 30.MEXICO INFECTION SURVEILLANCE SERVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 31.EUROPE INFECTION SURVEILLANCE SERVICES MARKET, BY OFFERING, 2020-2030 ($MILLION)
TABLE 32.EUROPE INFECTION SURVEILLANCE SERVICES MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 33.EUROPE INFECTION SURVEILLANCE SERVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 34.EUROPE INFECTION SURVEILLANCE SERVICES MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 35.GERMANY INFECTION SURVEILLANCE SERVICES MARKET, BY OFFERING, 2020-2030 ($MILLION)
TABLE 36.GERMANY INFECTION SURVEILLANCE SERVICES MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 37.GERMANY INFECTION SURVEILLANCE SERVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 38.FRANCE INFECTION SURVEILLANCE SERVICES MARKET, BY OFFERING, 2020-2030 ($MILLION)
TABLE 39.FRANCE INFECTION SURVEILLANCE SERVICES MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 40.FRANCE INFECTION SURVEILLANCE SERVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 41.UK INFECTION SURVEILLANCE SERVICES MARKET, BY OFFERING, 2020-2030 ($MILLION)
TABLE 42.UK INFECTION SURVEILLANCE SERVICES MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 43.UK INFECTION SURVEILLANCE SERVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 44.ITALY INFECTION SURVEILLANCE SERVICES MARKET, BY OFFERING, 2020-2030 ($MILLION)
TABLE 45.ITALY INFECTION SURVEILLANCE SERVICES MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 46.ITALY INFECTION SURVEILLANCE SERVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 47.SPAIN INFECTION SURVEILLANCE SERVICES MARKET, BY OFFERING, 2020-2030 ($MILLION)
TABLE 48.SPAIN INFECTION SURVEILLANCE SERVICES MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 49.SPAIN INFECTION SURVEILLANCE SERVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 50.REST OF EUROPE INFECTION SURVEILLANCE SERVICES MARKET, BY OFFERING, 2020-2030 ($MILLION)
TABLE 51.REST OF EUROPE INFECTION SURVEILLANCE SERVICES MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 52.REST OF EUROPE INFECTION SURVEILLANCE SERVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 53.ASIA-PACIFIC INFECTION SURVEILLANCE SERVICES MARKET, BY OFFERING, 2020-2030 ($MILLION)
TABLE 54.ASIA-PACIFIC INFECTION SURVEILLANCE SERVICES MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 55.ASIA-PACIFIC INFECTION SURVEILLANCE SERVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 56.ASIA-PACIFIC INFECTION SURVEILLANCE SERVICES MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 57.JAPAN INFECTION SURVEILLANCE SERVICES MARKET, BY OFFERING, 2020-2030 ($MILLION)
TABLE 58.JAPAN INFECTION SURVEILLANCE SERVICES MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 59.JAPAN INFECTION SURVEILLANCE SERVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 60.CHINA INFECTION SURVEILLANCE SERVICES MARKET, BY OFFERING, 2020-2030 ($MILLION)
TABLE 61.CHINA INFECTION SURVEILLANCE SERVICES MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 62.CHINA INFECTION SURVEILLANCE SERVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 63.AUSTRALIA INFECTION SURVEILLANCE SERVICES MARKET, BY OFFERING, 2020-2030 ($MILLION)
TABLE 64.AUSTRALIA INFECTION SURVEILLANCE SERVICES MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 65.AUSTRALIA INFECTION SURVEILLANCE SERVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 66.INDIA INFECTION SURVEILLANCE SERVICES MARKET, BY OFFERING, 2020-2030 ($MILLION)
TABLE 67.INDIA INFECTION SURVEILLANCE SERVICES MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 68.INDIA INFECTION SURVEILLANCE SERVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 69.REST OF ASIA-PACIFIC INFECTION SURVEILLANCE SERVICES MARKET, BY OFFERING, 2020-2030 ($MILLION)
TABLE 70.REST OF ASIA-PACIFIC INFECTION SURVEILLANCE SERVICES MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 71.REST OF ASIA-PACIFIC INFECTION SURVEILLANCE SERVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 72.LAMEA INFECTION SURVEILLANCE SERVICES MARKET, BY OFFERING, 2020-2030 ($MILLION)
TABLE 73.LAMEA INFECTION SURVEILLANCE SERVICES MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 74.LAMEA INFECTION SURVEILLANCE SERVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 75.LAMEA INFECTION SURVEILLANCE SERVICES MARKET, BY COUNTRY, 2020-2030 ($MILLION)
TABLE 76.BRAZIL INFECTION SURVEILLANCE SERVICES MARKET, BY OFFERING, 2020-2030 ($MILLION)
TABLE 77.BRAZIL INFECTION SURVEILLANCE SERVICES MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 78.BRAZIL INFECTION SURVEILLANCE SERVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 79.SAUDI ARABIA INFECTION SURVEILLANCE SERVICES MARKET, BY OFFERING, 2020-2030 ($MILLION)
TABLE 80.SAUDI ARABIA INFECTION SURVEILLANCE SERVICES MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 81.SAUDI ARABIA INFECTION SURVEILLANCE SERVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 82.SOUTH AFRICA INFECTION SURVEILLANCE SERVICES MARKET, BY OFFERING, 2020-2030 ($MILLION)
TABLE 83.SOUTH AFRICA INFECTION SURVEILLANCE SERVICES MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 84.SOUTH AFRICA INFECTION SURVEILLANCE SERVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 85.REST OF LAMEA INFECTION SURVEILLANCE SERVICES MARKET, BY OFFERING, 2020-2030 ($MILLION)
TABLE 86.REST OF LAMEA INFECTION SURVEILLANCE SERVICES MARKET, BY INFECTION TYPE, 2020-2030 ($MILLION)
TABLE 87.REST OF LAMEA INFECTION SURVEILLANCE SERVICES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 88.ALPHA: COMPANY SNAPSHOT
TABLE 89.ALPHA: OPERATING SEGMENTS
TABLE 90.ALPHA: PRODUCT PORTFOLIO
TABLE 91.BAXTER: COMPANY SNAPSHOT
TABLE 92.BAXTER: OPERATING SEGMENTS
TABLE 93.BAXTER: PRODUCT PORTFOLIO
TABLE 94.BAXTER: KEY DEVELOPMENTS
TABLE 95.BD: COMPANY SNAPSHOT
TABLE 96.BD: OPERATING SEGMENTS
TABLE 97.BD: PRODUCT PORTFOLIO
TABLE 98.BIOVIGIL: COMPANY SNAPSHOT
TABLE 99.BIOVIGIL: PRODUCT SEGMENTS
TABLE 100.BIOVIGIL: PRODUCT PORTFOLIO
TABLE 101.BIOVIGIL: KEY DEVELOPMENTS
TABLE 102.GOJO: COMPANY SNAPSHOT
TABLE 103.GOJO: PRODUCT SEGMENTS
TABLE 104.GE: PRODUCT PORTFOLIO
TABLE 105.IBM: COMPANY SNAPSHOT
TABLE 106.IBM: PRODUCT SEGMENTS
TABLE 107.IBM: PRODUCT PORTFOLIO
TABLE 108.PREMIER: COMPANY SNAPSHOT
TABLE 109.PREMIER: OPERATING SEGMENTS
TABLE 110.PREMIER: PRODUCT PORTFOLIO
TABLE 111.PREMIER: KEY DEVELOPMENTS
TABLE 112.RL: COMPANY SNAPSHOT
TABLE 113.RL: OPERATING SEGMENTS
TABLE 114.RL: PRODUCT PORTFOLIO
TABLE 115.PREMIER: KEY DEVELOPMENTS
TABLE 116.JOHNSON: COMPANY SNAPSHOT
TABLE 117.JOHNSON: OPERATING BUSINESS SEGMENTS
TABLE 118.JOHNSON: PRODUCT PORTFOLIO
TABLE 119.JOHNSON: KEY DEVELOPMENTS
TABLE 120.WOLTERS: COMPANY SNAPSHOT
TABLE 121.WOLTERS: OPERATING BUSINESS SEGMENTS
TABLE 122.WOLTERS: PRODUCT PORTFOLIO
TABLE 123.WOLTERS: KEY DEVELOPMENTS
Similar Reports
Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...
- Publish Date: August 21, 2016
- $5370
Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...
- Publish Date: December 1, 2016
- $5370
Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-re...
- Publish Date: April 24, 2017
- $5370
